Ensysce Biosciences Inc. (ENSC)
7.02
0.27 (4.00%)
At close: Jan 15, 2025, 10:12 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 2.23M | 2.52M | 3.53M | 3.93M | 1.76M | n/a | n/a |
| Cost of Revenue | 7.59M | 19.84M | 151.00 | 1.37M | 3.33M | 1.56M | n/a |
| Gross Profit | -5.36M | -17.31M | 3.53M | 2.56M | -1.56M | -1.56M | n/a |
| Operating Income | -10.72M | -24.22M | -19.87M | -1.61M | -3.33M | -959.24K | -146.70K |
| Interest Income | n/a | 1.25M | 3.22M | 719.65K | 4.25M | 3.63M | n/a |
| Pretax Income | -10.63M | -24.21M | -29.15M | -160.88K | 921.15K | 2.68M | -27.56K |
| Net Income | -10.61M | -24.96M | -29.15M | -938.73K | 1.48M | -1.34M | -31.19K |
| Selling & General & Admin | 5.36M | 6.91M | 18.71M | 1.15M | 3.33M | 1.56M | 146.69K |
| Research & Development | 7.59M | 19.84M | 4.69M | 4.39M | 3.40M | n/a | n/a |
| Other Expenses | -7.59M | -2.52M | -3.53M | -3.93M | n/a | 600.00K | n/a |
| Operating Expenses | 5.36M | 24.22M | 19.87M | 1.61M | 3.33M | 959.25K | 146.69K |
| Interest Expense | 353.94K | 109.53K | 1.30M | 995.50K | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -3.60M | n/a | n/a |
| Cost & Expenses | 12.95M | 24.22M | 19.87M | 1.61M | 3.33M | 959.24K | 146.69K |
| Income Tax | n/a | 753.88K | -151 | 777.85K | -555.20K | 553.92K | 3.63K |
| Shares Outstanding (Basic) | 2.26M | 179.93K | 84.02K | 65.70K | 98.26K | 104.02K | 105.00K |
| Shares Outstanding (Diluted) | 2.26M | 179.93K | 84.02K | 68.78K | 98.26K | 104.02K | 105.00K |
| EPS (Basic) | -4.69 | -138.73 | -346.9 | -14.29 | 15.02 | -12.91 | -0.3 |
| EPS (Diluted) | -4.69 | -138.73 | -346.9 | -13.65 | 15.02 | -12.91 | -0.3 |
| EBITDA | -10.72M | -24.22M | -19.87M | -1.61M | 921.15K | 2.68M | -27.55K |
| Depreciation & Amortization | -3 | 151.00 | 151.00 | 201.00 | 201.00 | 161.14K | n/a |